Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 0.04 USD 17.65% Market Closed
Market Cap: 280k USD

Wall Street
Price Targets

AXDX Price Targets Summary
Accelerate Diagnostics Inc

There are no price targets for AXDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Accelerate Diagnostics Inc Competitors:
Price Targets
ANGO
AngioDynamics Inc
43% Upside
300003
Lepu Medical Technology Beijing Co Ltd
32% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
9% Upside
DXCM
Dexcom Inc
31% Upside
MDG
Medicalgorithmics SA
46% Upside
605186
Shanghai General Healthy Information and Technology Co Ltd
37% Upside
NVST
Envista Holdings Corp
4% Upside
DRIO
DarioHealth Corp
81% Upside

Revenue
Forecast

Revenue Estimate
Accelerate Diagnostics Inc

For the last 12 years the compound annual growth rate for Accelerate Diagnostics Inc's revenue is 38%. The projected CAGR for the next 1 year is 7%.

38%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Accelerate Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Accelerate Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXDX's stock price target?
Not Available

AXDX doesn't have any price targets made by Wall Street professionals.

What is Accelerate Diagnostics Inc's Revenue forecast?
Projected CAGR
7%

For the last 12 years the compound annual growth rate for Accelerate Diagnostics Inc's revenue is 38%. The projected CAGR for the next 1 year is 7%.

Back to Top